RECRUITING

Feasibility of Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies

Description

This clinical trial evaluates the use of microdialysis catheters during surgery to collect biomarkers, and studies the feasibility of intraoperative microdialysis during neurosurgery for central nervous system malignancies. A biomarker is a measurable indicator of the severity or presence of disease state. Information collected in this study may help doctors to develop new strategies to better diagnose, monitor, and treat brain tumors.

Study Overview

Study Details

Study overview

This clinical trial evaluates the use of microdialysis catheters during surgery to collect biomarkers, and studies the feasibility of intraoperative microdialysis during neurosurgery for central nervous system malignancies. A biomarker is a measurable indicator of the severity or presence of disease state. Information collected in this study may help doctors to develop new strategies to better diagnose, monitor, and treat brain tumors.

Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies

Feasibility of Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies

Condition
Anaplastic Astrocytoma
Intervention / Treatment

-

Contacts and Locations

Rochester

Mayo Clinic in Rochester, Rochester, Minnesota, United States, 55905

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age \>= 18 years
  • * Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2
  • * Diagnosis of the following, based on clinical and radiographic evidence:
  • * A diffuse glioma, or a prior diagnosis of a diffuse glioma. Diffuse gliomas include diffuse astrocytoma, anaplastic astrocytoma, glioblastoma, oligodendroglioma and anaplastic oligodendroglioma
  • * Metastatic brain tumor of any primary origin
  • * Epileptic focus requiring surgical resection
  • * Planned neurosurgical procedure for purposes of biopsy or resection of suspected or previously diagnosed brain tumor (primary or metastatic) or epileptic focus as part of routine clinical care
  • * Willing to undergo neurosurgical resection or biopsy at Mayo Clinic (Rochester, Minnesota \[MN\])
  • * Ability to understand and the willingness to sign a written informed consent document
  • * Vulnerable populations: pregnant women, prisoners or the mentally handicapped
  • * Patients who are not appropriate candidates for surgery due to current or past medical history or uncontrolled concurrent illness

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Mayo Clinic,

Terence C Burns, M.D., Ph.D., PRINCIPAL_INVESTIGATOR, Mayo Clinic in Rochester

Study Record Dates

2027-09-01